{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-035166","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2024-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.344262+00:00","generated_at":"2026-05-31T06:11:40.543130+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oragenics raises $4.45M in public offering; sold shares and pre-funded warrants at $0.55","bullets":["Gross proceeds of ~$4.45M from offering of 3,078,378 shares and 5,028,206 pre-funded warrants.","Net proceeds ~$3.79M after placement agent fees (7%) and estimated expenses.","Proceeds to fund ONP-002 development for mild traumatic brain injury and general working capital.","Post-offering shares outstanding: 8,659,071 common shares plus 5,028,206 pre-funded warrants.","Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold at 125% of offering price."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-035166","json":"https://secwatch.observer/filing/0001493152-24-035166.json","markdown":"https://secwatch.observer/filing/0001493152-24-035166.md","text":"https://secwatch.observer/filing/0001493152-24-035166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/0001493152-24-035166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:11:40.543130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}